Overview

Intralesional Injections of Triamcinolone for Acne Vulgaris

Status:
Completed
Trial end date:
2023-02-14
Target enrollment:
Participant gender:
Summary
This proof-of-concept study seeks to investigate the safety of intralesional injections of triamcinolone for acne vulgaris lesions using an Intradermal Needle Adapter.
Phase:
N/A
Details
Lead Sponsor:
ACOM Labs
Treatments:
Triamcinolone